Published online Jul 24, 2025. doi: 10.5306/wjco.v16.i7.107246
Revised: April 26, 2025
Accepted: June 18, 2025
Published online: July 24, 2025
Processing time: 125 Days and 20 Hours
Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare heterogeneous primary malignant liver tumor containing both hepatocellular and cholangiocarcinoma features. The complex presentation of cHCC-CCA tends to be poorly investigated, and the information derived from traditional diagnostic techniques (histopathology and radiological imaging) is often not optimal. Since cHCC-CCA is usually difficult to diagnose due to complex histopathological features (edge learning) as excessive photos, hence, achieves treatment delays and poor prognosis, the incorporation of advanced artificial intelligence like edge learning is able to improve the patient’s outcome. Using artificial intelligence, particularly deep learning, has recently opened new doorways for the impro
Core Tip: Edge learning presents a novel approach in combined hepatocellular-cholangiocarcinoma diagnosis and classification, leveraging decentralized artificial intelligence for real-time processing and enhanced data privacy. Unlike traditional cloud-based artificial intelligence, edge learning enables on-site analysis of histopathological features and medical imaging (computed tomography, magnetic resonance imaging) while reducing latency and bandwidth usage. This review explores its technical integration, including federated learning, deep learning optimizations (convolutional neural networks, pruning, quantization), and privacy-preserving artificial intelligence frameworks. By overcoming challenges like diagnostic complexity and data security, edge learning enhances clinical decision-making, treatment planning, and diagnostic accuracy, offering a transformative potential in precision oncology and liver cancer management.
